In this clinical trial, 50 patients referred to Imam Reza Hospital with unilateral fracture of the mandible and indications for intra-oral Open Reduction treatment will be randomly selected and randomly divided into 5 groups. In this double-blind study, the surgeon and patients will be blinded to the study.
Inclusion criteria: Patients with unilateral mandibular fracture
Exclusion criteria: Duration of surgery more than 2 hours; Drug abuse by patients; History of systemic disease, History of drug allergy
In Group A, immediately before induction of anesthesia a ketorolac 30 mg ampule, in Group B, immediately before induction of anesthesia a ketorolac 60 mg ampule, in Group C, immediately before the completion of surgery a ketorolac 30 mg ampule, in group D, immediately after the completion of surgery a ketorolac 60 mg ampule will be injected intravenously. It will not be injected for the Group E. After consciousness of the patient, intensity of pain(primary outcome variable) whit a numerical scale VAS at 0, 2, 4, 6, 12, 24 hours will be measured. Data from the study will be analyzed using appropriate statistical methods.